ProEthic Pharmaceuticals was founded in 2001. ProEthic has been established to provide a broad diversity of pharmaceutical products to better serve physicians and their patients. It is a specialty pharmaceutical company which promotes its own branded prescription products to physicians across many specialties. It also has an active drug development program with two products currently in Phase III clinical trials. ProEthic has been established to provide a broad diversity of pharmaceutical products to better serve physicians and their patients. The company's focus was initially directed at the physicians who treated respiratory disease. This group included allergists, pulmonologists and primary care physicians. As the product portfolio has grown, other specialties have been added and now also include urology, rheumatology and pain management. ProEthic's objective is to establish a superior sales organization while pursuing an aggressive strategy of new drug acquisition through the in-licensing or acquisition of existing proprietary products.